Your browser doesn't support javascript.
loading
A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction.
Rao, Sunil V; Kirsch, Bodo; Bhatt, Deepak L; Budaj, Andrzej; Coppolecchia, Rosa; Eikelboom, John; James, Stefan K; Jones, W Schuyler; Merkely, Bela; Keller, Lars; Hermanides, Renicus S; Campo, Gianluca; Ferreiro, José Luis; Shibasaki, Taro; Mundl, Hardi; Alexander, John H.
Afiliación
  • Rao SV; New York University Langone Health System, New York, NY (S.V.R.).
  • Kirsch B; Bayer AG, Wuppertal, Germany (B.K., L.K., H.M.).
  • Bhatt DL; Brigham and Women's Hospital, Harvard Medical School, Boston, MA (D.L.B.).
  • Budaj A; Centre of Postgraduate Medical Education, Grochowski Hospital, Warsaw, Poland (A.B.).
  • Coppolecchia R; Bayer US LLC, Whippany, NJ (R.C.).
  • Eikelboom J; Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada (J.E.).
  • James SK; Department of Medical Sciences and Uppsala Clinical Research Center, Uppsala University, Sweden (S.K.J.).
  • Jones WS; Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC (W.S.J., J.H.A.).
  • Merkely B; Heart and Vascular Center, Semmelweis University, Budapest, Hungary (B.M.).
  • Keller L; Bayer AG, Wuppertal, Germany (B.K., L.K., H.M.).
  • Hermanides RS; Isala Hospital, Zwolle, The Netherlands (R.S.H.).
  • Campo G; Cardiovascular Institute, Azienda Ospedaliero-Universitaria di Ferrara, Cona, Italy (G.C.).
  • Ferreiro JL; Department of Cardiology, Bellvitge University Hospital, BIOHEART: Cardiovascular Diseases Group-IDIBELL, CIBERCV, l'Hospitalet de Llobregat, Barcelona, Spain (J.L.F.).
  • Shibasaki T; Saitama Sekishinkai Hospital, Saitama, Japan (T.S.).
  • Mundl H; Bayer AG, Wuppertal, Germany (B.K., L.K., H.M.).
  • Alexander JH; Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC (W.S.J., J.H.A.).
Circulation ; 146(16): 1196-1206, 2022 10 18.
Article en En | MEDLINE | ID: mdl-36030390
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Síndrome Coronario Agudo / Intervención Coronaria Percutánea / Infarto del Miocardio Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies Límite: Aged / Female / Humans / Male Idioma: En Revista: Circulation Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Síndrome Coronario Agudo / Intervención Coronaria Percutánea / Infarto del Miocardio Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies Límite: Aged / Female / Humans / Male Idioma: En Revista: Circulation Año: 2022 Tipo del documento: Article